Truxima is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cephalon, Inc.. The primary component is Rituximab.
Product ID | 63459-104_0805ccb0-7bf3-4ecb-bbaa-febed8858040 |
NDC | 63459-104 |
Product Type | Human Prescription Drug |
Proprietary Name | Truxima |
Generic Name | Rituximab-abbs |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-05-04 |
Marketing Category | BLA / BLA |
Application Number | BLA761088 |
Labeler Name | Cephalon, Inc. |
Substance Name | RITUXIMAB |
Active Ingredient Strength | 10 mg/mL |
Pharm Classes | CD20-directed Antibody Interactions [MoA],CD20-directed Cytolytic Antibody [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-05-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA761088 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2020-05-04 |
Ingredient | Strength |
---|---|
RITUXIMAB | 10 mg/mL |
SPL SET ID: | 9af3ddc7-4217-417a-ac89-8704edc5bc44 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63459-103 | Truxima | rituximab-abbs |
63459-104 | Truxima | rituximab-abbs |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRUXIMA 88452656 not registered Live/Pending |
CELLTRION, INC. 2019-05-30 |
TRUXIMA 79168237 4962045 Live/Registered |
CELLTRION, INC. 2015-02-27 |